Church & Dwight Co., Inc. (CHD) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly report (Form 10-Q) for Church & Dwight Co., Inc. for the period ended June 30, 2025. The company develops, manufactures, and markets consumer household and personal care products (e.g., ARM & HAMMER, OXICLEAN, THERABREATH) and specialty products. The company operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division (SPD).
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Net Sales | $1,506.3M | $1,511.2M | $2,973.4M | $3,014.5M |
| Gross Profit | $647.0M | $712.1M | $1,306.6M | $1,399.1M |
| Gross Margin | 43.0% | 47.1% | 43.9% | 46.4% |
| Operating Income | $261.7M | $336.9M | $557.0M | $641.9M |
| Operating Margin | 17.5% | 22.3% | 18.7% | 21.3% |
| Net Income | $191.0M | $243.5M | $411.1M | $471.2M |
| Diluted EPS | $0.78 | $0.99 | $1.66 | $1.91 |
| Cash & Equivalents | $923.2M (as of June 30, 2025) | |||
| Long-Term Debt | $2,205.8M (as of June 30, 2025) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 0.3% in Q2 and 1.4% YTD compared to 2024. The decline was driven by unfavorable pricing/mix in the Consumer Domestic segment and the exit of specific product lines (Flawless, Spinbrush, Waterpik showerheads).
- Margin Compression: Gross margin decreased 410 basis points in Q2 and 250 basis points YTD. This was primarily due to a $51.0M pre-tax charge related to exiting businesses ($30.4M in Cost of Sales, $20.6M in SG&A), higher manufacturing costs (labor, commodities, tariffs), and unfavorable price/mix.
- Operating Income Drop: Operating income fell 22.3% in Q2 and 13.2% YTD, largely attributable to the aforementioned exit charges and increased costs.
- Segment Performance:
- Consumer Domestic: Sales down 1.4% (Q2) and 2.2% (YTD); Operating income down significantly due to exit charges and higher costs.
- Consumer International: Sales up 5.3% (Q2) and 4.0% (YTD), driven by volume growth in HERO and THERABREATH brands.
- SPD: Sales down 3.0% (Q2) and 6.3% (YTD) due to prior divestitures and lower volumes.
Guidance, Outlook, and Management Commentary
- Strategic Exits: The company announced the exit of Flawless, Spinbrush, and Waterpik showerhead businesses, expected to be completed by early 2026. These businesses generated ~$170M in 2024 sales.
- Vitamin Business Review: A strategic review of the vitamin business (VITAFUSION, L'IL CRITTERS) is underway, with potential actions including supply chain streamlining, joint ventures, or divestiture. A conclusion is expected by end of 2025.
- Acquisitions: Completed the acquisition of Touchland (hand sanitizer) on July 16, 2025, for $700M (including stock and earn-out potential). This is a subsequent event not reflected in the Q2 financials.
- Tariff Exposure: Management projects a twelve-month run-rate gross tariff cost of approximately $60M, though they aim to reduce this through supply chain shifts and pricing.
- Capital Allocation:
- Share Repurchases: Entered an Accelerated Share Repurchase (ASR) in May 2025 for $300M. $658.9M remains available under the 2021 program.
- Dividends: Quarterly dividend increased to $0.295 per share (4% increase).
- Debt: Entered a new $2,000M credit facility in July 2025 (subsequent event).
Investor Verification Checklist
- Exit Execution: Verify the timeline and financial impact of exiting the Flawless, Spinbrush, and Waterpik showerhead businesses.
- Vitamin Strategy: Monitor the outcome of the strategic review for the VITAFUSION/L'IL CRITTERS business line.
- Tariff Mitigation: Assess the company's ability to offset the projected $60M annual tariff cost through pricing and supply chain changes.
- Touchland Integration: Evaluate the integration progress and revenue contribution of the new Touchland acquisition.
- Working Capital: Review the cash conversion cycle, which increased slightly to 30 days, driven by changes in accounts payable and receivable timing.